Clinical trial
Mainstreaming of Clinical Genomic Sequencing for Rare Disease in Ontario, Canada: Protocol for a Province-wide Hybrid Type 2 Implementation-effectiveness Trial
NCT07799792 is registered in ClinicalTrials.gov with The Hospital for Sick Children as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mainstreaming of Clinical Genomic Sequencing for Rare Disease in Ontario, Canada: Protocol for a Province-wide Hybrid Type 2 Implementation-effectiveness Trial
- Lead sponsor
- The Hospital for Sick Children
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- September 1, 2026
- Completion date
- August 31, 2027
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
evaluation of mainstreamed models of genetic service delivery, genetic disease, neurodevelomental disorders